PMID: 2503080Jun 3, 1989Paper

Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme

BMJ : British Medical Journal
E M SmithG M Masson

Abstract

To evaluate the effect of support with human chorionic gonadotrophin in the luteal phase in women taking part in an in vitro fertilisation programme after buserelin and human menopausal gonadotrophin were used to hyperstimulate their ovaries. Controlled group comparison. Outpatient department of a private hospital. 115 Women with indications for in vitro fertilisation, all of whom had at least one embryo transferred. After suppression of the pituitary with buserelin the ovaries of all the women were stimulated with human menopausal gonadotrophin on day 4 of the luteal phase. Human chorionic gonadotrophin (10,000 IU) was given to induce ovulation, and oocytes were recovered 34 hours later. Embryos were transferred 46 to 48 hours after insemination. Women who had received the 10,000 IU of human chorionic gonadotrophin on a date that was an uneven number (n = 61) were allocated to receive support doses of 2500 IU human chorionic gonadotrophin three and six days after that date. The remaining 54 women did not receive hormonal support. Determination of the rates of pregnancy. MEASUREMENTS and main results--Support with human chorionic gonadotrophin did not significantly alter the progesterone or oestradiol concentrations in the earl...Continue Reading

References

Jan 1, 1985·Annals of the New York Academy of Sciences·C M BaylyA L Speirs
Dec 1, 1985·Journal of in Vitro Fertilization and Embryo Transfer : IVF·M M MahadevanP J Taylor
Jun 1, 1984·Fertility and Sterility·S MuasherH W Jones

❮ Previous
Next ❯

Citations

Jun 1, 1991·Journal of in Vitro Fertilization and Embryo Transfer : IVF·J H CheckC Callan
Jun 1, 1992·Journal of Assisted Reproduction and Genetics·D R MeldrumB Marr
Mar 16, 2000·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·D M CosteaT Chard
Dec 8, 2000·Steroids·D de Ziegler, R Fanchin
Jun 14, 2002·Journal of Reproductive Immunology·A TavaniotouP Devroey
May 1, 2001·Acta Obstetricia Et Gynecologica Scandinavica·M Ludwig, K Diedrich
May 12, 2009·Advanced Drug Delivery Reviews·Margit M Janát-AmsburyC Matthew Peterson
Mar 1, 1995·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·J BalaschJ A Vanrell
Jul 8, 2015·The Cochrane Database of Systematic Reviews·Michelle van der LindenMostafa Metwally
Mar 24, 2005·Gynecologic and Obstetric Investigation·Saleema NosarkaDebbie Grové
Jul 23, 2008·The Cochrane Database of Systematic Reviews·Salim Daya, Joanne L Gunby
Nov 1, 1993·British Journal of Obstetrics and Gynaecology·P VandekerckhoveT W Harada
Dec 8, 2000·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·F MartinezP N Barri
Jan 1, 1995·Journal of Endocrinological Investigation·P G ArtiniA R Genazzani
Aug 20, 1990·The Medical Journal of Australia·R P JansenE Ciancaglini
May 9, 2003·Reproductive Biomedicine Online·Alan S Penzias, Michael M Alper

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.